Beta-Amyloid Peptides Enhance the Proliferative Response of Activated CD4+CD28+ Lymphocytes from Alzheimer Disease Patients and from Healthy Elderly. Here, CD4 is linked to early-onset autosomal dominant Alzheimer disease.